Early Experiences with Intrathecal Administration of Amphotericin B Liposomal Formulation at a Neurosurgical Center

被引：0
|
作者：
Michael D. Nailor
Kellie J. Goodlet
Omar Gonzalez
J. Tyler Haller
机构：
[1] St. Joseph’s Hospital and Medical Center,Department of Pharmacy Services
[2] Midwestern University College of Pharmacy,Department of Pharmacy Practice
[3] Arizona Pulmonary Specialists,Infectious Disease Division
[4] Barrow Neurological Institute,undefined
[5] St. Joseph Hospital and Medical Center,undefined
来源：
CNS Drugs | 2024年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 229
页数：4
相关论文
共 50 条
  • [31] A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatment
    Isnard, Francoise
    Tilleul, Patrick
    Laporte, Jean-Philippe
    Chevallier, Patrice
    Pigneux, Arnaud
    Lafuma, Antoine
    Mahi, Lamine
    Deray, Gilbert
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (10) : 3090 - 3091
  • [32] Evaluation of hypokalemia and potassium supplementation during administration of liposomal-amphotericin B
    Usami, Eiseki
    Kimura, Michio
    Kanematsu, Tetsufumi
    Yoshida, Shinya
    Mori, Takayuki
    Nakashima, Keiji
    Matsuoka, Tomoko
    Yoshimura, Tomoaki
    Mori, Hiromi
    Sugiyama, Tadashi
    Teramachi, Hitomi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (04) : 941 - 946
  • [33] Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model
    Mishra, Jyotsna
    Dey, Ayan
    Singh, Niti
    Somvanshi, Ramesh
    Singh, Sarman
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2013, 137 : 767 - 776
  • [34] Evaluation of size-based distribution of drug and excipient in amphotericin B liposomal formulation
    Van Haute, Desiree
    Jiang, Wenlei
    Mudalige, Thilak
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 569
  • [35] Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation
    Mohr, JF
    Hall, AC
    Ericsson, CD
    Ostrosky-Zeichner, L
    PHARMACOTHERAPY, 2005, 25 (03): : 426 - 428
  • [36] THERAPEUTIC EFFICACY OF A LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) AGAINST MURINE BLASTOMYCOSIS
    CLEMONS, KV
    STEVENS, DA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (03) : 465 - 472
  • [37] TREATMENT OF MURINE CANDIDOSIS AND CRYPTOCOCCOSIS WITH A UNILAMELLAR LIPOSOMAL AMPHOTERICIN-B FORMULATION (AMBISOME)
    ADLERMOORE, JP
    CHIANG, SM
    SATORIUS, A
    GUERRA, D
    MCANDREWS, B
    MCMANUS, EJ
    PROFFITT, RT
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 : 63 - 71
  • [38] Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients
    Rocio, Carolina
    Amato, Valdir Sabbaga
    Camargo, Raphael A.
    Tuon, Felipe F.
    Nicodemo, Antonio Carlos
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2014, 108 (03) : 176 - 178
  • [39] Impact of the Administration of Liposomal Amphotericin B in Patients with Renal Function Impairment at Initiation of Treatment
    Alvarez-Lerma, F.
    Mariscal, F.
    Quin-Tana, E.
    Rialp, G.
    Diaz-Reganon, J.
    San Jose, M. J. Perez
    Alvarez-Sanchez, B.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (04) : 285 - 287
  • [40] Acute refractory hyperkalaemia and fatal cardiac arrest related to administration of liposomal amphotericin B
    Groot, O. A.
    Trof, R. J.
    Girbes, A. R.
    Swart, N. L.
    Beishuizen, A.
    NETHERLANDS JOURNAL OF MEDICINE, 2008, 66 (10): : 433 - 437
12345